HealthDay - Dr. Douglas Dieterich: "Study Finds too Few with Hepatitis C Start or Stick with Treatment"
A new study suggests that only a quarter of people with hepatitis C are willing to start the standard treatment for the serious viral infection. When interferon injections - the current standard treatment - work, which only happens about 16 percent of the time, the risk of dying drops by 45 percent. "This study points out the inadequacies of old therapies for hepatitis C," said Douglas Dieterich, MD, a Professor of Medicine and Liver Diseases, and Director of Continuing Medical Education at the Icahn School of Medicine at Mount Sinai. Learn more